Pricing politics

Presidential candidates from both parties are tapping into public anger over prescription drug prices and responding by repeating old proposals, like controlling prices or lowering FDA approval standards, that won't be enacted and probably wouldn't work if they were put into practice.

Out of the limelight and far from the political pontification, the renewed attention to drug prices is stimulating quieter discussions about new approaches to drug spending that might benefit patients, the healthcare system and developers of innovative medicines. ...